MAIN ARTICLE
An ordinary wish after years of treatment
What Lu wants is strikingly modest. In the account SCMP attributes to Jimu News, he describes wanting to feel ordinary, even if freedom from medication lasts only a limited time. For someone living with a chronic illness, that wish reaches beyond a prescription. It touches the organisation of work, repeated appointments and the psychological weight of planning around treatment. The pill count makes the years visible, while leaving much of that daily experience unmeasured.
In early October, he attended the First Affiliated Hospital of Soochow University in Suzhou, Jiangsu province. SCMP reports that doctors suggested halving his medication and reassessing him with a test three months later. These are reported details of his individual care, not a published clinical record. The available account does not establish that he will remain off treatment indefinitely. His story is therefore about an anticipated possibility, with another medical assessment still ahead.
Stopping medication requires a monitoring plan
The 2025 European LeukemiaNet recommendations recognise treatment-free remission for selected CML patients with a sustained deep molecular response and specialist monitoring. A single negative result does not establish permanent eradication of disease. Reducing or stopping medication is an individual medical decision; readers should not copy a treatment plan described in a news report.

















